Secukinumab in pregnancy: outcomes in psoriasis, psoriatic arthritis and ankylosing spondylitis from the global safety database

Br J Dermatol. 2018 Nov;179(5):1205-1207. doi: 10.1111/bjd.16901. Epub 2018 Sep 11.

R B Warren¹, K Reich², R G Langley³, B Strober^{4

5}, D Gladman⁶, A Deodhar⁷, T Bachhuber⁸, W Bao⁹, E Altemeyer¹⁰, S Hussain¹¹, J Safi Jr⁹

¹ The Dermatology Centre, Salford Royal NHS Foundation Trust, NIHR Biomedical Research Centre, The University of Manchester, Manchester, U.K.
² Dermatologikum Berlin and SCIDerm Research Institute, Hamburg, Germany.
³ Dalhousie University, Halifax, NS, B3H, Canada.
⁴ University of Connecticut Health Center, Farmington, CT, U.S.A.
⁵ Probity Medical Research, Waterloo, ON, Canada.
⁶ Toronto Western Hospital, Toronto, ON, Canada.
⁷ Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR, U.S.A.
⁸ Novartis Pharma GmbH, Nuremberg, Germany.
⁹ Novartis Pharmaceuticals Corporation, East Hanover, NJ, U.S.A.
¹⁰ Novartis Ireland Ltd, Dublin, Ireland.
¹¹ Novartis Healthcare Pvt Ltd, Hyderabad, India.

No abstract available

Publication types